↓ Skip to main content

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury

Overview of attention for article published in Cardiovascular Diabetology, July 2018
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
Published in
Cardiovascular Diabetology, July 2018
DOI 10.1186/s12933-018-0750-8
Pubmed ID
Authors

Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter, Javad Habibi, Guanghong Jia, Francisco I. Ramirez-Perez, Luis Martinez-Lemus, Camila M. Manrique-Acevedo, Melvin R. Hayden, Cornel Duta, Ravi Nistala, Eric Mayoux, Jaume Padilla, Bysani Chandrasekar, Vincent G. DeMarco

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 18%
Student > Master 11 18%
Student > Ph. D. Student 7 12%
Student > Doctoral Student 4 7%
Researcher 4 7%
Other 9 15%
Unknown 14 23%
Readers by discipline Count As %
Medicine and Dentistry 18 30%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Biochemistry, Genetics and Molecular Biology 6 10%
Sports and Recreations 5 8%
Nursing and Health Professions 3 5%
Other 5 8%
Unknown 17 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2019.
All research outputs
#10,792,244
of 14,207,392 outputs
Outputs from Cardiovascular Diabetology
#542
of 817 outputs
Outputs of similar age
#186,847
of 270,879 outputs
Outputs of similar age from Cardiovascular Diabetology
#1
of 1 outputs
Altmetric has tracked 14,207,392 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 817 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,879 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them